Debbie Shawcross

Debbie Shawcross is a Clinical Professor of Hepatology and Chronic Liver Failure at the Institute of Liver Studies, King’s College London. She serves as a Consultant Hepatologist at King’s Liver Unit, focusing on hepatic encephalopathy, liver failure syndromes, and cirrhosis complications.

• Education: PhD (UCL), MBBS (Imperial College London), BSc (Imperial College London)

Her research characterizes the immunobiology of chronic liver failure, emphasizing the gut-liver-brain axis and gut microbiome’s role in immune dysfunction, inflammation, and encephalopathy. She leads clinical trials in faecal microbiota transplantation (FMT) across Europe, including the NIHR-funded PROMISE Trial (FMT for cirrhosis).

Key scientific recognitions include:

• Elected Vice Secretary General of EASL (2023)
• Juan Rodes State of the Art Lecture in Portal Hypertension (2024)
• Young Investigator Award (2008)

She has held leadership roles in gastroenterology education, such as Health Education England London Gastroenterology Training Programme Director (10 years), and chairs the British Society of Gastroenterology (BSG) Research Committee. Her work aligns with UN SDG goals for health and education equity.